Correlation Between Biomm SA and Vertex Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biomm SA and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomm SA and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomm SA and Vertex Pharmaceuticals Incorporated, you can compare the effects of market volatilities on Biomm SA and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomm SA with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomm SA and Vertex Pharmaceuticals.

Diversification Opportunities for Biomm SA and Vertex Pharmaceuticals

0.47
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Biomm and Vertex is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Biomm SA and Vertex Pharmaceuticals Incorpo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and Biomm SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomm SA are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of Biomm SA i.e., Biomm SA and Vertex Pharmaceuticals go up and down completely randomly.

Pair Corralation between Biomm SA and Vertex Pharmaceuticals

Assuming the 90 days trading horizon Biomm SA is expected to under-perform the Vertex Pharmaceuticals. In addition to that, Biomm SA is 2.41 times more volatile than Vertex Pharmaceuticals Incorporated. It trades about -0.03 of its total potential returns per unit of risk. Vertex Pharmaceuticals Incorporated is currently generating about 0.17 per unit of volatility. If you would invest  61,748  in Vertex Pharmaceuticals Incorporated on December 30, 2024 and sell it today you would earn a total of  9,532  from holding Vertex Pharmaceuticals Incorporated or generate 15.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Biomm SA  vs.  Vertex Pharmaceuticals Incorpo

 Performance 
       Timeline  
Biomm SA 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Biomm SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Biomm SA is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Vertex Pharmaceuticals 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Vertex Pharmaceuticals Incorporated are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Vertex Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

Biomm SA and Vertex Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biomm SA and Vertex Pharmaceuticals

The main advantage of trading using opposite Biomm SA and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomm SA position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.
The idea behind Biomm SA and Vertex Pharmaceuticals Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format